---
figid: PMC11411235__mmr-30-05-13324-g02
figtitle: Functions of tetraspanins in liver cancer
organisms:
- NA
organisms_ner:
- Homo sapiens
pmcid: PMC11411235
filename: mmr-30-05-13324-g02.jpg
figlink: /pmc/articles/PMC11411235/figure/F3/
number: F3
caption: 'Functions of tetraspanins in liver cancer. (A) Tetraspanins promoting HCC
  progression: (a) TSPAN15 enhances ERK phosphorylation and ADAM10 secretion, controls
  CTGF expression and secretion and promotes HCC cell proliferation. (b) miR-135b
  targets TSPAN31, increasing CDK4 protein levels, which promotes HCC cell invasion
  and migration. (c) TSPAN8 promotes HCC cell metastasis by inducing ADAM12. (d) TSPAN24/CD151
  induces metastasis through integrin β1, induces MMP9 expression, promotes cancer
  cell migration and contributes to angiogenesis and HCC metastasis. (e) TSPAN30/CD63
  activates the TGF-β and FAK-Akt signaling pathways by binding to TIMP-1, promoting
  HCC cell migration and survival. (f) TSPAN5 activation of Notch signaling enhances
  EMT-promoted metastasis in tumor cells. (g) TSPAN1 regulates HCC cell proliferation
  by targeting the PI3K/Akt pathway. (B) Tetraspanins suppressing HCC progression:
  (a) TSPAN27 binds to integrins and E-cadherin, affecting the invasive and metastatic
  potential of HCC cells. (b) TSPAN29/CD9 blocks the activation of JNK and c-JUN,
  leading to the inhibition of HCC cell proliferation in vitro. (c) TSPAN7/CD231 upregulation
  suppresses the growth of HCC cells. HCC, hepatocellular carcinoma; TSPAN, tetraspanin;
  ADAM10/12, ADAM metalloproteinase 10/12; CTGF, connective tissue growth factor;
  miR, microRNA; CDK, cyclin-dependent kinase; MMP, matrix metalloproteinase; FAK,
  focal adhesion kinase; TIMP-1, tissue inhibitors of metalloproteinase-1; EMT, epithelial-mesenchymal
  transition; JNK, c-JUN N-terminal kinase'
papertitle: 'Tetraspanins in digestive‑system cancers: Expression, function and therapeutic
  potential (Review)'
reftext: Kexin Chen, et al. Mol Med Rep. 2024 Nov;30(5).
year: '2024'
doi: 10.3892/mmr.2024.13324
journal_title: Molecular Medicine Reports
journal_nlm_ta: Mol Med Rep
publisher_name: D.A. Spandidos
keywords: biomarkers | clinical significance | digestive-system cancers | molecular
  mechanisms | tetraspanins
automl_pathway: 0.9342784
figid_alias: PMC11411235__F3
figtype: Figure
redirect_from: /figures/PMC11411235__F3
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC11411235__mmr-30-05-13324-g02.html
  '@type': Dataset
  description: 'Functions of tetraspanins in liver cancer. (A) Tetraspanins promoting
    HCC progression: (a) TSPAN15 enhances ERK phosphorylation and ADAM10 secretion,
    controls CTGF expression and secretion and promotes HCC cell proliferation. (b)
    miR-135b targets TSPAN31, increasing CDK4 protein levels, which promotes HCC cell
    invasion and migration. (c) TSPAN8 promotes HCC cell metastasis by inducing ADAM12.
    (d) TSPAN24/CD151 induces metastasis through integrin β1, induces MMP9 expression,
    promotes cancer cell migration and contributes to angiogenesis and HCC metastasis.
    (e) TSPAN30/CD63 activates the TGF-β and FAK-Akt signaling pathways by binding
    to TIMP-1, promoting HCC cell migration and survival. (f) TSPAN5 activation of
    Notch signaling enhances EMT-promoted metastasis in tumor cells. (g) TSPAN1 regulates
    HCC cell proliferation by targeting the PI3K/Akt pathway. (B) Tetraspanins suppressing
    HCC progression: (a) TSPAN27 binds to integrins and E-cadherin, affecting the
    invasive and metastatic potential of HCC cells. (b) TSPAN29/CD9 blocks the activation
    of JNK and c-JUN, leading to the inhibition of HCC cell proliferation in vitro.
    (c) TSPAN7/CD231 upregulation suppresses the growth of HCC cells. HCC, hepatocellular
    carcinoma; TSPAN, tetraspanin; ADAM10/12, ADAM metalloproteinase 10/12; CTGF,
    connective tissue growth factor; miR, microRNA; CDK, cyclin-dependent kinase;
    MMP, matrix metalloproteinase; FAK, focal adhesion kinase; TIMP-1, tissue inhibitors
    of metalloproteinase-1; EMT, epithelial-mesenchymal transition; JNK, c-JUN N-terminal
    kinase'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - TSPAN15
  - TSPAN31
  - CDK4
  - FOLR1
  - FOSL1
  - RABEP2
  - AKT1
  - AKT2
  - AKT3
  - TSPAN8
  - CD151
  - CD63
  - TSPAN5
  - TSPAN1
  - ADAM12
  - CD82
  - CD9
  - CDH1
  - FZR1
  - TSPAN7
  - NOTCH1
  - NOTCH2
  - NOTCH3
  - NOTCH4
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - GSK3B
  - TGFB1
  - TGFB2
  - TGFB3
  - PRKAR1A
  - PRKAR1B
  - PRKAR2A
  - PRKAR2B
  - PRKACA
  - PRKACB
  - PRKACG
  - KLKB1
  - RIPK4
  - PAK1
  - PAK2
  - PAK3
  - PAK4
  - PAK5
  - PAK6
  - SNAI1
  - MMP9
  - Man
  - cancer
  - liver cancer
---
